An effusion may be the presenting sign of malignant disease or the first indication of recurrence. Identification of tumour cells in the fluid is an important first line investigation. In a proportion of cases the malignant cells are easily recognised, but in some fluids they are not seen or cannot be confidently identified with the use of routine staining methods. Immunocytochemical techniques increase the diagnostic accuracy. '`6 Monoclonal antibodies have been used in panels and singly with various techniques on both histological and cytological material.7-9 These methods require expensive reagents and considerable technical time and expertise. This paper records the reaction of Cal antibody with a series of effusion fluids received in two district general hospitals. The objective was to see if expenditure on this monoclonal antibody applied to specimens prepared by routine laboratory techniques improved the diagnosis based on morphological characteristics alone. A second monoclonal antibody, HMFG2 (antihuman milk fat globule membrane),'0 was introduced in a smaller series to see if it increased further the accuracy of diagnosis.
Material and methods

PATIENTS AND SPECIMENS
A total of 178 consecutive specimens of pleural and Accepted for publication 24 October 1984 ascitic fluid received in the cytology laboratories of two district general hospitals were stained with the Cal antibody using the immunoalkaline phosphatase technique. From the results, 11 specimens were discounted because they contained only blood. Histological confirmation of the diagnosis was sought from the patient's records when the series was complete. 
Atypical
In these nine cases which had shown morphological (Table 3 ). The reaction was distinct and appeared to be similar to that given by the Cal antibody. It was generally stronger than the Cal reaction and was less focal, with most of the malignant cells shown. The two negative cases were a small cell carcinoma and a follicular lymphoma.
Negatve
No reaction was shown with the HMFG2 antibody in 10 of the 18 benign effusions. In the remaining eight effusions the mesothelial cells were stained pink. This reaction was not as strong as a positive reaction but it was more intense than the pale pink blush that occurred in seven benign effusions with the Cal antibody.
Atypical
No smears from the atypical effusions were available for use with the HMFG2 antibody.
Discussion
This study was designed to see whether the use of monoclonal antibodies could increase the accuracy of the diagnosis of malignancy in effusions in a routine hospital cytology laboratory. Traditionally, this diagnosis relies on the experience of individuals using smears stained by the Papanicolaou and May-Grunwald Giemsa techniques supported by a histochemical method for mucins. A negative report issued on this evidence means that malignant cells were not recognised. 
